CSIMarket


Novavax inc  (NASDAQ: NVAX)
Other Ticker:  
 

Novavax inc

NVAX's Fundamental analysis








Novavax Inc's sales fell by -69.69 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 1677

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.61 %

Novavax Inc net loss decreased from $-178 millions, to $-81 millions in IV. Quarter 2024,

More on NVAX's Growth


Novavax Inc
realized a net loss in trailing twelve months.

Novavax Inc realized cash reduction of $ -0.25 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.69.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.52.


More on NVAX's Valuation
 
 Total Debt (Millions $) 170
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 451,763
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 10.63
 Tangible Book Value (Per Share $) -4.80

Novavax Inc
realized net loss in trailing twelve months.

Novavax Inc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.69.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.52.


More on NVAX's Valuation

  Market Capitalization (Millions $) 1,152
  Shares Outstanding (Millions) 152
  Employees 1,510
  Revenues (TTM) (Millions $) 682
  Net Income (TTM) (Millions $) -188
  Cash Flow (TTM) (Millions $) -39
  Capital Exp. (TTM) (Millions $) -15
  Total Debt (Millions $) 170
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 451,763
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 10.63
  Tangible Book Value (Per Share $) -4.80

  Market Capitalization (Millions $) 1,152
  Shares Outstanding (Millions) 152
  Employees 1,510
  Revenues (TTM) (Millions $) 682
  Net Income (TTM) (Millions $) -188
  Cash Flow (TTM) (Millions $) -39
  Capital Exp. (TTM) (Millions $) -15





  Ratio
   Capital Ratio (MRQ) 0.98
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.47
  Inventory Turnover Ratio (TTM) 19.15





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com